3,923
Views
60
CrossRef citations to date
0
Altmetric
Report

Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule

, , , , , , , , , , & show all
Pages 1205-1211 | Received 27 Mar 2015, Accepted 17 Aug 2015, Published online: 26 Sep 2015

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.